Objective Interferon‐α (IFNα) is a primary pathogenic factor in systemic lupus erythematosus
(SLE), and high IFNα levels may be associated with particular clinical manifestations. The …

PURPOSE: Systemic lupus erythematosus (SLE) can significantly affect both health and non-health-related
quality of life (HRQOL and non-HRQOL). However, of the existent published …

Increased IFN-α signaling is a heritable risk factor for systemic lupus erythematosus (SLE).
IFN induced with helicase C domain 1 (IFIH1) is a cytoplasmic dsRNA sensor that activates …

Objective Interferon‐α (IFNα) is a heritable risk factor for systemic lupus erythematosus (SLE).
Genetic variation near IRF7 is implicated in SLE susceptibility. SLE‐associated …

Background: Patient-reported outcomes are valuable for the management of chronic diseases
like systematic lupus erythematosus (SLE), but no measures have been validated for use …

Introduction Systemic lupus erythematosus (SLE) is a highly heterogeneous disorder,
characterized by differences in autoantibody profile, serum cytokines, and clinical manifestations. …

Objective To evaluate serum free light chains (FLC) as a putative biomarker of systemic lupus
erythematosus (SLE) activity. Methods Seventy‐five SLE patients and 41 age‐ and sex‐…

Objective. Health related quality of life (HRQOL) is an important patient-reported outcome in
systemic lupus erythematosus (SLE). We evaluated the psychometric properties of 2 widely …

Background Systemic lupus erythematosus (SLE), a multisystemic disease of young women
may be disfiguring and affect physical and emotional health. Body image literature in SLE is …

Objective Biomechanical interventions for knee osteoarthritis (OA) aim to improve pain and
retard disease progression by decreasing knee loading. This study was undertaken to …